Indeed, evaluation of phospho-H2AX (Ser139)(hereafter γH2AX), a surrogate marker of DSBs [37], indicated that SN-38 treatment induced higher levels of DSBs in EwS in comparison to non-EwS sarcoma cells (Fig. 1E). This evidence concerns the gene H2AX and sarcoma.